Comment on

• Prevalence and prognostic significance of preprocedural cardiac troponin elevation among patients with stable coronary artery disease undergoing percutaneous coronary intervention: results from the evaluation of drug eluting stents and ischemic events registry.

  Jeremias A, Kleiman NS, Nassif D, Hsieh WH, Pencina M, Maresh K, Parikh M, Cutlip DE, Waksman R, Goldberg S, Berger PB, Cohen DJ; Evaluation of Drug Eluting Stents and Ischemic Events (EVENT) Registry Investigators. Jeremias A, et al. Circulation. 2008 Aug 5;118(6):632-8. doi: 10.1161/CIRCULATIONAHA.107.752428. Epub 2008 Jul 21. Circulation. 2008. PMID: 18645057
• What do you need to know before performing a percutaneous coronary intervention?

  Cavender MA, Ohman EM. Cavender MA, et al. Circulation. 2008 Aug 5;118(6):609-11. doi: 10.1161/CIRCULATIONAHA.108.791848. Circulation. 2008. PMID: 18678781 No abstract available.
• Significance of periprocedural myonecrosis on outcomes after percutaneous coronary intervention: an analysis of preintervention and postintervention troponin T levels in 5487 patients.

  Prasad A, Rihal CS, Lennon RJ, Singh M, Jaffe AS, Holmes DR Jr. Prasad A, et al. Circ Cardiovasc Interv. 2008 Aug;1(1):10-9. doi: 10.1161/CIRCINTERVENTIONS.108.765610. Circ Cardiovasc Interv. 2008. PMID: 20031650